360ONE WAM (360ONE) reported an operating revenue of INR6.6b (in line), reflecting 10% YoY growth in 1QFY26. This was driven by a 36% YoY growth in ARR income to INR5.1b (7% beat), offset by a 32% YoY decline in TBR income to INR1.5b (8% miss).
ARR AUM rose 30% YoY to INR2.9t (10% beat), while ...
Search found 663 matches
- Sat Jul 19, 2025 7:55 pm
- Forum: Discussions about stocks
- Topic: 360ONE WAM is a compelling structural growth story says Motilal Oswal
- Replies: 0
- Views: 7
- Fri Jul 18, 2025 8:26 pm
- Forum: Discussions about stocks
- Topic: LTIM has a target price of ₹6200 and is a good buy
- Replies: 0
- Views: 24
LTIM has a target price of ₹6200 and is a good buy
LTIMindtree posted decent Q1FY26 results, in line with our estimates. Revenue came in at USD1,153mn, +0.8% CC QoQ (+4.4% YoY), in line with our estimate. EBIT margin expanded 50bp QoQ to 14.3%, in line with our estimate. TCV rose +1.9% QoQ/+16.4% YoY to USD1.63bn.
Over the last two years, LTIM has ...
Over the last two years, LTIM has ...
- Thu Jul 17, 2025 7:45 pm
- Forum: Discussions about stocks
- Topic: Axis has recommended Buy of Cera Sanitaryware for target price of ₹8500
- Replies: 0
- Views: 59
Axis has recommended Buy of Cera Sanitaryware for target price of ₹8500
We initiate coverage of Cera Sanitaryware Ltd. with a BUY recommendation and a target price of Rs 8,500/share, implying a potential upside of 31% from the CMP.We expect Revenue/EBITDA/PAT CAGR of 10%/9%/9% from FY24-FY27E.Cera is engaged in the business of manufacturing, selling, and trading various ...
- Wed Jul 16, 2025 8:08 pm
- Forum: Discussions about stocks
- Topic: Vishal Mega Mart is a buy for Target Price of ₹165
- Replies: 0
- Views: 206
Vishal Mega Mart is a buy for Target Price of ₹165
Vishal Mega Mart (VMM) is one of India’s largest offline-first value retailers, catering to a population of ~1b across the middle- and low-income segments. VMM is a unique Indian retailer with: 1) a strong presence in tier 2+ cities (696 stores in 458 cities); 2) well-diversified exposure to key ...
- Tue Jul 15, 2025 8:49 pm
- Forum: Discussions about stocks
- Topic: Kalyan Jewellers is a good buy for target price of ₹700 says JM
- Replies: 0
- Views: 157
Kalyan Jewellers is a good buy for target price of ₹700 says JM
Kalyan Jewellers was founded by T S Kalyanaraman – who has over 45 years of retail experience with 25 years in the jewellery industry – in 1993 with one showroom in Thrissur. By FY25, it had 278 stores in India. It entered the Middle East in 2014 and operates 36 showrooms in the region (Mar-27), and ...
- Mon Jul 14, 2025 8:01 pm
- Forum: Discussions about stocks
- Topic: Motilal Oswal is bullish about Laxmi Dental for target price of ₹540
- Replies: 0
- Views: 143
Motilal Oswal is bullish about Laxmi Dental for target price of ₹540
Laxmi Dental (Laxmiden) is distinguished as India’s only fully integrated provider of dental solutions, led by a highly experienced management team with extensive expertise in the field.
Over the past two decades, the company has established an extensive Business-toBusiness-to-Consumer (B2B2C ...
Over the past two decades, the company has established an extensive Business-toBusiness-to-Consumer (B2B2C ...
- Sun Jul 13, 2025 8:33 pm
- Forum: Discussions about stocks
- Topic: TCS is quoting at compelling valuations & is a buy for target price of ₹3908
- Replies: 0
- Views: 251
TCS is quoting at compelling valuations & is a buy for target price of ₹3908
TCS reported revenue decline in 1Q, primarily due to the ramp-down in BSNL deal. Barring India, the company posted a disappointing 0.5% QoQ revenue decline. The weakness is attributable to the cautious discretionary spending in international markets. Clients are taking longer to finalize decisions ...
- Sat Jul 12, 2025 9:05 pm
- Forum: Discussions about stocks
- Topic: Abbott India is immune from US tariff woes & can be bought for Target Price of ₹40128
- Replies: 0
- Views: 269
Abbott India is immune from US tariff woes & can be bought for Target Price of ₹40128
Ascribing valuation in line with its peer GSK
▪ Novo’s oral semaglutide Rybelsus is growing at a robust 173% CAGR over a 3Y period to Rs 4bn, as on MAT MAY’25
▪ Abbott’s in-licensed Insulin sales as on MAT MAY’25 — Mixtard Rs 7.6bn, Ryzodeg Rs 6bn, Novomix Rs 3.6bn, Actrapid Rs 2.3bn
▪ Due to ...
▪ Novo’s oral semaglutide Rybelsus is growing at a robust 173% CAGR over a 3Y period to Rs 4bn, as on MAT MAY’25
▪ Abbott’s in-licensed Insulin sales as on MAT MAY’25 — Mixtard Rs 7.6bn, Ryzodeg Rs 6bn, Novomix Rs 3.6bn, Actrapid Rs 2.3bn
▪ Due to ...
- Fri Jul 11, 2025 7:58 pm
- Forum: Discussions about stocks
- Topic: Anant Raj has 45% upside gain says Emkay
- Replies: 0
- Views: 245
Anant Raj has 45% upside gain says Emkay
We reiterate BUY on Anant Raj with an unchanged TP of Rs800. The company has announced the commissioning of its second Data Center (DC) facility at Panchkula, and is also expanding its existing capacity at Manesar, Haryana. We expect operations to start over the next two months, with annualized ...
- Thu Jul 10, 2025 8:05 pm
- Forum: Discussions about stocks
- Topic: JM is bullish about Tips Music & has recommended buy for 24% upside
- Replies: 0
- Views: 292
JM is bullish about Tips Music & has recommended buy for 24% upside
We initiate coverage on Tips Music Ltd (Tips Music) with a BUY rating and a DCF-based Mar’26 TP of INR 800 (implied FY27E PER of 40x, PEG of 1.7x). It is one of the leading music labels in India (top 5) and delivered above-industry growth of 36% over FY21-25 by expanding its catalogue (hits from the ...